Abstract
Using gel filtration chromatography (GFC), we found that human VLDL, LDL and HDL transport ≈0.03, 0.2 and 3% of plasma T4. As T4 could dissociate from carriers during GFC, we evaluated [125I]T4 transport to lipoproteins (Lp) in 50 normolipidemic and euthyroid subjects by GFC and 2 independent methods: zone electrophoresis (ZE) and radioimmunoprecipitation (RIP). At GFC, VLDL+LDL transported less T4 (≈0.3%) than either ZE (≈1.3%) or RIP (≈1.5–2.0%). In contrast, GFC values for the HDL (≈3%) were close to the RIP values (≈3.5%), but lower than ZE (≈8.5%) because of partial co-migration with TBG. In conclusion, GFC underestimates T4 binding to VLDL and LDL, which, indeed, is of the same magnitude as binding of some steroid hormones to CBG and SHBG. Hence, the anti-atherosclerotic effects of T4 resulting from binding to the LDL should be greater than anticipated based on GFC data.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Benvenga S., Gregg R.E., Robbins J.: Binding of thyroid hormones to human plasma lipoproteins. J. Clin. Endocrinol. Metab. 1988, 67: 6–16.
Benvenga S., Robbins J.: Altered thyroid hormone binding to plasma lipoproteins in hypothyroidism. Thyroid 1996, 6: 595–600.
Benvenga S., Robbins J.: Lipoprotein-thyroid hormone interactions. Trends Endocrinol. Metab. 1993, 4: 194–198.
Benvenga S.: The 27-kilodalton thyroxine (T4)-binding protein is human apolipoprotein A-I: identification of a 68-kilodalton high density lipoprotein that binds T4. Endocrinology 1989, 124: 1265–1269.
Orth N.O., Kovacs W.J.: The adrenal cortex. In: Wilson J.D., Foster D.W., Kronenberg D.W., Larsen P.R. (Eds.), Williams’ textbook of endocrinology. W.B. Saunders, Philadelphia, 1998, p. 517.
Robbins J.: Thyroid hormone transport proteins and the physiology of hormone binding. In: Braverman L.E., Utiger R.D. (Eds.), Werner and Ingbar’s The thyroid. Lippincott Williams & Wilkins, Philadelphia, 2000, p. 105.
Bandinelli R., Ciampi G., Pasquinelli F., Piazza E. Lipidi.: In: Pasquinelli F (Ed.), Diagnostica e tecnica di laboratorio. Chimica clinica pura parte I. Edizioni Rosini, Firenze, 1979, p. 512.
Manual of Laboratory Operations: Lipid Research Clinic Program, vol 1. Lipid and Lipoprotein Analysis. DHEW Publication No. 75–628, NHLBI, Bethesda, 1974, p. 60.
Benvenga S., Bartolone L., Squadrito S., Trimarchi F.: Thyroid hormone autoantibodies elicited by diagnostic fine needle biopsy. J. Clin. Endocrinol. Metab. 1997, 82: 4217–4223.
Klein I.: Thyroid hormone and the cardiovascular system. Am. J. Med. 1990, 88: 631–637.
Witzum J.: The oxidation hypothesis of atherosclerosis. Lancet 1994, 344: 793–795.
Dieckman M.J.M., Demacker P.N., Kastelein J.J., Stalenhoef A.F., Wiersinga W.M.: Increased oxidazibility of low-density lipoproteins in hypothyroidism. J. Clin. Endocrinol. Metab. 1998, 83: 1752–1755.
Benvenga S., Cahnmann H.J., Robbins J.: Localization of the thyroxine binding sites in apolipoprotein B100 of human low-density lipoproteins. Endocrinology 1990, 127: 2241–2246.
Benvenga S.: Effect of thyroxine on low density lipoprotein oxidation. Another thyroid hormone nongenomic effect. J. Clin. Endocrinol. Metab. 1998, 83: 3337–3378.
Benvenga S., Cahnmann H., Rader D., Kindt M., Facchiano A., Robbins J.: Thyroid hormone binding to apolipoproteins A-II, AIV, C-I, C-II and C-III: homology in thyroxine binding sites. Thyroid 1994, 4: 261–267.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Benvenga, S., Lapa, D. & Trimarchi, F. Re-evaluation of the thyroxine binding to human plasma lipoproteins using three techniques. J Endocrinol Invest 24, RC16–RC18 (2001). https://doi.org/10.1007/BF03343863
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03343863